Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05645510

LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study

Conditions: Cancer, Tyrosine Kinase Mutation, Breast Cancer, Melanoma, Multiple Myeloma, Chronic Leukemia, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Lung Cancer

Sex: All
Ages: 18 Years – 90 Years
Enrollment: 75
Sponsor: University of Alberta

Location: Canada

Summary

People with advanced chronic cancers are now living for many years as a result of new targeted anti-cancer treatments. Many of these treatments are quite new and people may take them for months, even years, as long as the treatments are helping. The purpose of this study is to help understand how to best support people receiving these treatments.

Eligibility Criteria

Inclusion Criteria: taking chronic targeted anti-cancer agents -Exclusion Criteria:-

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05645510). StuddyBuddy aggregates publicly available trial information.